InvestorsHub Logo
Followers 32
Posts 2803
Boards Moderated 3
Alias Born 10/24/2015

Re: jondoeuk post# 51

Friday, 02/16/2018 3:43:08 PM

Friday, February 16, 2018 3:43:08 PM

Post# of 108
They hope to present monotherapy data at a medical meeting (hopefully ESMO or SITC). This should include number of patients treated, ORR, DCR, biopsy data and/or biomarkers. The CEO also hopes the combo trial with Yervoy will happen before the 2H of this year and if enrolment is very fast then data from could be presented at either of these conferences too.